Recurrent Small Cell Lung Cancer (SCLC)
2 clinical trials · Condition
◉ Watch Recurrent Small Cell Lung Cancer (SCLC)
| Record | Firm | Date |
|---|---|---|
| Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer (NCT02312622) | Joel Neal | 2015-08-01 |
| Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer (NCT00698516) | GlaxoSmithKline | 2008-07-01 |
Track Recurrent Small Cell Lung Cancer (SCLC) automatically
Every clearance here is in the API, with alerts when new ones post.